1/30
Looks like no tags are added yet.
CCD Risk Factors
Non-Modifable
Male > 45
Female > 55
Family history of premature CAD event
Male < 55
Female < 65
Modifiable
Smoking
HTN
Dyslipidemia
Obesity
Diabetes
Physical Inactivity
Typical Angina, Atypical, Non-Cardiac
Typical
Occurs with characteristic quality, location, duration
Provoked
Relieved by nitroglycerin or rest
Atypical
Meets only 2 of the 3 criteria
Occurs with Women, older adults, and diabetesC
Non-Cardiac
meets 1 or none of the above
Chronic Coronary Disease Subtypes
Stable Angina
Discharged ACS → considered to have CCD
CCD Diagnosed on Screening
Acute Coronary Syndrome Subtypes
Unstable Angina
frequency or duration increases, acute change
NSTEMI
partial occlusion
troponin elevation
primary and secondary hemostasis
STEMI
full occlusion
troponin elevation
ST elevation / ECG change
primary and secondary hemostasis
Plaque Rupture Flow
Primary Hemostasis (quick)
1. adhesion → adhere to collagen in subendothelium, released von willebrand factor
2. activation → release ADP, Ca2+, thromboxane A2
3. aggregation → forms platelet plug
Secondary Hemostasis
Fibrin clot → through coagulation cascade
Diagnosis of CAD
Gold Standard → Coronary Angiogram/cathetirization
Exercise & nuclear stress tests → abnormal results = coronary angiogram
Coronary artery CT scan → abnormal results = coronary angiogram
Coronary Artery Calcium Test → abnormal results = coronary angiogram
PKPD of Nitrates
Short Acting
SL or Spray → onset 1-3 minutes for 10-30 minutes
keep tabs in original container
2% ointment → onset 15-30 minutes for 3-6 hours
Long Acting
Isosorbide dinitrate → onset 60 minutes for 4-6 hours
mononitrate duration 6-10 hours
Transdermal Patch
Nitrate tolerance → Provide 10-14 hour nitrate free period (during sleep)
Anginal Impacts of Nitrates
Beneficial
↓ Ventricular volume
↓ Arterial pressure
↓ Ejection time
Deleterious
Reflex Tachycardia
Reflex ↑ contractility
Anginal Impacts of CCB
Beneficial
Both = ↓ myocardial contractile force
Non-DHP = Antiadrenergic
Non-DHP = ↓ HR
Deleterious
Reflex Tachycardia
Anginal Impacts of BB
Beneficial
↓ myocardial contractile force
Antiadrenergic
↓ HR
Anginal Impacts of Ranolazine
↓ Myocardial contractile force
Does NOT affect HR or BP
Aspirin Formulation Onsets of Action
Chewed → 20 minutes
Non-Enteric Coated → < 1 hour
Enteric Coated → 3-4 hours
PKPD Antiplatelet Considerations
Clopidogrel
d/c surgery 5 days
Ticagrelor
d/c surgery 3-5 days
contraindicated → cerebral bleeding, severe liver disease
max aspirin dose 100mg
avoid CYP3A4 inducers/inhibitors
Prasugrel
d/c surgery 7 days
contraindicated → stroke / TIA
relative CI → < 60 kg, > 75 yrs
CCD Treatment → Lipids
Not High Risk
High Intensity Statin
moderate if can’t tolerate
if LDL >70 add ezetimibe
If LDL < 100 but TG 150-499 add IPE
High Risk
High Intensity Statin
if LDL >70 add ezetimibe
If LDL < 100 but TG 150-499 add IPE
If LDL > 70 or non-HDL > 100 add PCSK9i
CCD Treatment → Antiplatelet
No PCI → 81 aspirin daily
PCI (stent) → DAPT 1-6 months, then SAPT
SAPT = clopidogrel or aspirin
CABG → DAPT
DAPT = low dose aspirin + clopidogrel or ticagrelor
CCD Anginal Chest Pain Treatment Algorithm
Antianginal therapy with beta blocker, CCB, or long acting nitrate
Who remain symptomatic → add second anti-anginal in different class
Who remain symptomatic → add ranolazine
Can start Ranolazine on patients who have very low BP
SL or spray Nitroglycerin recommended for immediate short term relief
replace tabs Q6 months
replace spray Q3 years (insurance might not cover)
(ACD) Acute Treatment Strategies
Unstable Angina & NSTEMI
Medical therapy
Coronary Angiogram
findings → stent or CABG
OSNAAP
STEMI
Immediate Coronary Angiogram or FIBRINOLYTIC
Only start fibrinolytic if time to cath lab > 120 minutes
Alteplase, Reteplase, Tenecteplase*
OSNAAP → O
If Oxygen Saturation <90% → give supplemental oxygen
OSNAAP → S
Initiate or continue High-Intensity Statin
Give dose even if they claim they took morning dose already
LDL <55 → continue high intensity therapy
LDL 55-69 → additional therapy recommended (ezetimibe)
LDL >70 → additional therapy (ezetimibe or PCSK9i)
OSNAAP → N
For rapid & effective pain relief
analgesics not shown to improve clinical outcomes
Sublingual Nitroglycerin every 5 minutes for 3 times
Administer IV Nitroglycerin for persistent ischemia, HF, or HTN
Able to add opiates if neither work
Morphine or Fentanyl
OSNAAP → A
Aspirin
Loading Dose → 162 - 325 mg CHEWABLE aspirin
typically 4 × 81mg aspirin
OSNAAP → A
Acute Coronary Syndrome → Heparin
Enoxaparin & Fondaparinux as alternatives
During PCI (Stent) → Heparin
Enoxaparin & Bivalirudin as alternatives
Duration → until time of PCI or CABG
OSNAAP → P (dosing)
P2Y12 Inhibitor
Loading Dose
Ticagrelor → 1× 180mg
Prasugrel → 1× 60mg
Clopidogrel → 1× 300-600mg
If using lytic:
<75 → 300mg, >75 → 75mg
Maintenance Dose (1-12 months)
Ticagrelor → 90mg BID
Prasugrel → 10mg
Clopidogrel → 75mg
OSNAAP → P (initial strategy)
PCI (Unstable Angina, NSTEMI, STEMI)
Aspirin + Ticagrelor / Prasugrel
CABG
Aspirin + Ticagrelor / Clopidogrel
No Planned Invasive Evaluation
Aspirin + Ticagrelor
Fibrinolytic in STEMI
Aspirin + Clopidogrel
SNAP BAM Treatment
S → Statin → continue high intensity
N → Nitroglycerin → SL PRN Rx
A → Aspirin → non-enteric coated 81mg
P → P2Y12i → continue maintenance dose for 1-12 months (DAPT)
followed by SAPT with Aspirin or Clopidogrel
B → BB → 1yr or indefinitely
can use lower initial doses; not using for BP
don’t use in acute HF
A → ACEi/ARB → indefinitely
can use lower initial doses; not using for BP
If HFrEF, can use ARNi
M → MRA → indefinitely
ONLY if in HFrEF <40%
Cocaine Induced MI Treatment
Chest pain → Aspirin & Benzodiazepine
Persistent HTN → IV NTG & Benzodiazepines
Possibly avoid BB
Drug abuse counseling
NSAID Risks Ranking
Diclofenac & Coxibs > Ibuprofen > Naproxen